Godefridus Peters

PROF.DR., (Principal Investigator)

1990 …2019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives against Pancreatic Cancer Cells*

Li Petri, G., Cascioferro, S., el Hassouni, B., Carbone, D., Parrino, B., Cirrincione, G., Peters, G. J., Diana, P. & Giovannetti, E., 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3615-3620

Research output: Contribution to journalArticleAcademicpeer-review

Breastfeeding during R-CHOP chemotherapy: please abstain!

Codacci-Pisanelli, G., Honeywell, R. J., Asselin, N., Bellettini, G., Peters, G. J., Giovannetti, E. & Peccatori, F. A., 1 Sep 2019, In : European Journal of Cancer. 119, p. 107-111 5 p.

Research output: Contribution to journalLetterAcademicpeer-review

Open Access

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Peters, G. J., Giovannetti, E., Honeywell, R. J. & Ciccolini, J., 2019, In : British Journal of Clinical Pharmacology.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

Noordhuis, P., Laan, A. C., van de Born, K., Honeywell, R. J. & Peters, G. J., 2019, In : International Journal of Molecular Sciences. 20, 15

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment

Kumar, M. S., Yadav, T. T., Khair, R. R., Peters, G. J. & Yergeri, M. C., 2019, In : Current pharmaceutical design. 25, 31, p. 3323-3338

Research output: Contribution to journalArticleAcademicpeer-review